Capital structure
Capital
Universe-wide view of capital raises, placements, dilution, and buybacks · last 12 months
Total raised
$361M
48 raises
Companies who raised
24
with shares disclosed
Median dilution
8.7%
across raisers
Buybacks
54.5M shares
$1383M deployed
Dilution Leaderboard
Most-diluted, last 12 months
New shares issued ÷ current shares on issue · sum across all placements / SPPs / rights issues
Active
24 / universe
48 raises
01
IPD
ImpediMed Limited
113.8%
$22M · 4x
02
N
NUZ
Neurizon Therapeutics
100.0%
$3M
03
PAB
Patrys
65.3%
$53M · 2x
04
PER
Percheron Therapeutics
54.4%
$2M · 2x
05
BOT
Botanix Pharmaceuticals
46.3%
$5M · 2x
06
ACR
Acrux
41.0%
$2M
07
PAR
Paradigm Biopharmaceuticals Limited
34.7%
$23M · 3x
08
PEB
Pacific Edge
33.7%
$51M · 2x
09
SNT
Syntara
27.2%
$10M · 3x
10
1AD
Adalta
24.5%
$3M
Placement Discount
Deepest-discounted raises, last 12 months
Issuer-disclosed discount where available; derived from prior-day close otherwise · deeper discount = greater dilution cost to existing holders
Priced
38
12 disclosed · 26 derived
All raises · last 12 months
CompanyTypePrice
10 June 2026IPDImpediMed Limitedspp$2M300.0M$0.007+16.7%
IPDImpediMed Limited
+16.7%10 June 2026·spp·$2M·300.0M shares·$0.007
8 June 2026PABPatrysplacement$50M2.1M$0.024−42.9%
PABPatrys
−42.9%8 June 2026·placement·$50M·2.1M shares·$0.024
4 June 2026RACRacura Oncologyplacement$1M0.5M$1.900−24.3%
RACRacura Oncology
−24.3%4 June 2026·placement·$1M·0.5M shares·$1.900
3 June 2026PEBPacific Edgeother$36M212.4M$0.170−24.4%
PEBPacific Edge
−24.4%3 June 2026·other·$36M·212.4M shares·$0.170
2 June 2026IPDImpediMed Limitedspp$2M200.0M$0.010+66.7%
IPDImpediMed Limited
+66.7%2 June 2026·spp·$2M·200.0M shares·$0.010
1 June 20264DX4DMedicalother$4M2.6M——
4DX4DMedical
—1 June 2026·other·$4M·2.6M shares·—
1 June 2026PARParadigm Biopharmaceuticals Limitedspp$7M43.4M$0.170+3.0%
PARParadigm Biopharmaceuticals Limited
+3.0%1 June 2026·spp·$7M·43.4M shares·$0.170
1 June 20264DX4DMedicalplacement$0.2M0.1M$4.001+0.8%
4DX4DMedical
+0.8%1 June 2026·placement·$0.2M·0.1M shares·$4.001
29 May 2026ADOAnteotechoptions exercise$8M214.3M$0.035−20.5%
ADOAnteotech
−20.5%29 May 2026·options exercise·$8M·214.3M shares·$0.035
29 May 2026PERPercheron Therapeuticsother$0.0M13.8M——
PERPercheron Therapeutics
—29 May 2026·other·$0.0M·13.8M shares·—
28 May 2026RACRacura Oncologyoptions exercise$2M1.8M$1.250−53.5%
RACRacura Oncology
−53.5%28 May 2026·options exercise·$2M·1.8M shares·$1.250
14 May 2026SNTSyntaraspp—74.1M$0.027+0.0%
SNTSyntara
+0.0%14 May 2026·spp·—·74.1M shares·$0.027
13 May 2026PEBPacific Edgeplacement————
PEBPacific Edge
—13 May 2026·placement·—·— shares·—
12 May 2026IPDImpediMed Limitedspp$2M———
IPDImpediMed Limited
—12 May 2026·spp·$2M·— shares·—
11 May 2026ACRAcruxplacement$2M168.4M$0.009−13.6%
ACRAcrux
−13.6%11 May 2026·placement·$2M·168.4M shares·$0.009
8 May 2026NOXNoxopharmother$0.1M2.0M——
NOXNoxopharm
—8 May 2026·other·$0.1M·2.0M shares·—
8 May 2026CHMChimeric Therapeuticsother$0.1M0.3M$0.158+9.0%
CHMChimeric Therapeutics
+9.0%8 May 2026·other·$0.1M·0.3M shares·$0.158
8 May 2026PEBPacific Edgeplacement$14M132.3M$0.109−27.4%
PEBPacific Edge
−27.4%8 May 2026·placement·$14M·132.3M shares·$0.109
4 May 2026CYPCynata Therapeuticsplacement$2M6.0M$0.250−22.5%
CYPCynata Therapeutics
−22.5%4 May 2026·placement·$2M·6.0M shares·$0.250
4 May 20261ADAdaltaplacement$3M625.0M$0.004−20.0%
1ADAdalta
−20.0%4 May 2026·placement·$3M·625.0M shares·$0.004
4 May 2026IPDImpediMed Limitedspp$3M300.0M$0.010−28.6%
IPDImpediMed Limited
−28.6%4 May 2026·spp·$3M·300.0M shares·$0.010
4 May 2026IPDImpediMed Limitedplacement$15M1520.0M$0.010−28.6%
IPDImpediMed Limited
−28.6%4 May 2026·placement·$15M·1520.0M shares·$0.010
4 May 2026IMRImricor Medical Systemsplacement$60M32.4M$1.850−6.3%
IMRImricor Medical Systems
−6.3%4 May 2026·placement·$60M·32.4M shares·$1.850
29 Apr 2026SNTSyntaraspp$2M74.1M$0.027−18.2%
SNTSyntara
−18.2%29 Apr 2026·spp·$2M·74.1M shares·$0.027
29 Apr 2026SNTSyntaraplacement$8M296.3M$0.027−18.2%
SNTSyntara
−18.2%29 Apr 2026·placement·$8M·296.3M shares·$0.027
27 Apr 2026PARParadigm Biopharmaceuticals Limitedplacement$14M73.7M$0.190−15.6%
PARParadigm Biopharmaceuticals Limited
−15.6%27 Apr 2026·placement·$14M·73.7M shares·$0.190
27 Apr 2026PARParadigm Biopharmaceuticals Limitedspp$2M10.5M$0.190−15.6%
PARParadigm Biopharmaceuticals Limited
−15.6%27 Apr 2026·spp·$2M·10.5M shares·$0.190
23 Apr 2026IMUImugenespp$2M15.1M$0.145+0.0%
IMUImugene
+0.0%23 Apr 2026·spp·$2M·15.1M shares·$0.145
23 Apr 2026ALAArovella Therapeuticsother$0.3M2.0M$0.125+62.3%
ALAArovella Therapeutics
+62.3%23 Apr 2026·other·$0.3M·2.0M shares·$0.125
20 Apr 2026PABPatrysplacement$3M133.3M$0.024−7.7%
PABPatrys
−7.7%20 Apr 2026·placement·$3M·133.3M shares·$0.024
16 Apr 2026NUZNeurizon Therapeuticsplacement$3M33.2M$0.080—
NUZNeurizon Therapeutics
—16 Apr 2026·placement·$3M·33.2M shares·$0.080
14 Apr 2026PERPercheron Therapeuticsrights issue$2M435.0M$0.005+11.1%
PERPercheron Therapeutics
+11.1%14 Apr 2026·rights issue·$2M·435.0M shares·$0.005
10 Apr 2026LDXLumos Diagnosticsspp$2M8.9M$0.225+18.4%
LDXLumos Diagnostics
+18.4%10 Apr 2026·spp·$2M·8.9M shares·$0.225
8 Apr 2026MSBMesoblastother—1.3M——
MSBMesoblast
—8 Apr 2026·other·—·1.3M shares·—
7 Apr 2026MSBMesoblastother—1.3M——
MSBMesoblast
—7 Apr 2026·other·—·1.3M shares·—
2 Apr 2026PERPercheron Therapeuticsrights issue——$0.005+0.0%
PERPercheron Therapeutics
+0.0%2 Apr 2026·rights issue·—·— shares·$0.005
31 Mar 2026CU6Clarity Pharmaceuticalsoptions exercise————
CU6Clarity Pharmaceuticals
—31 Mar 2026·options exercise·—·— shares·—
27 Mar 20264DX4DMedicalplacement$83M14.1M$5.900−6.1%
4DX4DMedical
−6.1%27 Mar 2026·placement·$83M·14.1M shares·$5.900
26 Mar 2026ACWActinogen Medicalplacement$0.7M15.9M$0.042+13.5%
ACWActinogen Medical
+13.5%26 Mar 2026·placement·$0.7M·15.9M shares·$0.042
24 Mar 2026PERPercheron Therapeuticsrights issue————
PERPercheron Therapeutics
—24 Mar 2026·rights issue·—·— shares·—
20 Mar 2026IMUImugeneplacement$6M35.5M$0.180+20.0%
IMUImugene
+20.0%20 Mar 2026·placement·$6M·35.5M shares·$0.180
19 Mar 2026ATHAlterity Therapeuticsother—150.0M$0.020+150.0%
ATHAlterity Therapeutics
+150.0%19 Mar 2026·other·—·150.0M shares·$0.020
19 Mar 2026ATHAlterity Therapeuticsoptions exercise—150.0M$0.020+150.0%
ATHAlterity Therapeutics
+150.0%19 Mar 2026·options exercise·—·150.0M shares·$0.020
18 Mar 20264DX4DMedicaloptions exercise—0.5M——
4DX4DMedical
—18 Mar 2026·options exercise·—·0.5M shares·—
11 Mar 2026CU6Clarity Pharmaceuticalsoptions exercise—0.2M——
CU6Clarity Pharmaceuticals
—11 Mar 2026·options exercise·—·0.2M shares·—
11 Mar 2026BOTBotanix Pharmaceuticalsspp$5M83.3M$0.060+9.1%
BOTBotanix Pharmaceuticals
+9.1%11 Mar 2026·spp·$5M·83.3M shares·$0.060
11 Mar 2026BOTBotanix Pharmaceuticalsspp—777.8M——
BOTBotanix Pharmaceuticals
—11 Mar 2026·spp·—·777.8M shares·—
27 Feb 2026ACWActinogen Medicalspp$17M114.0M$0.042+0.0%
ACWActinogen Medical
+0.0%27 Feb 2026·spp·$17M·114.0M shares·$0.042
Data is sourced from ASX capital_raise filings parsed by AI · prev close = trading day before announce_date. Dilution % = sum of new shares issued ÷ current shares on issue · gross of buybacks.